Beta-Lactam Plus Macrolide for Patients Hospitalized With Community-Acquired Pneumonia: Difference Between Autumn and Spring

BACKGROUND: The 2017 Korean guideline on community-acquired pneumonia (CAP) recommended beta-lactam plus macrolide combination therapy for patients hospitalized with severe pneumonia, and beta-lactam monotherapy for mild-to-moderate pneumonia. However, antibiotic treatment regimen for mild-to-modera...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yoonjung, Jeon, Yena, Kwon, Ki Tae, Bae, Sohyun, Hwang, Soyoon, Chang, Hyun-Ha, Kim, Shin-Woo, Lee, Won Kee, Yang, Ki-Hwa, Shin, Ji-Hyeon, Shim, Eun-Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678659/
https://www.ncbi.nlm.nih.gov/pubmed/36413797
http://dx.doi.org/10.3346/jkms.2022.37.e324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678659/
https://www.ncbi.nlm.nih.gov/pubmed/36413797
http://dx.doi.org/10.3346/jkms.2022.37.e324

Ejemplares similares